Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia in dental patients.

J Adriani, R Sundin

    Journal of the American Dental Association (1939)
    |February 1, 1984
    PubMed
    Summary

    Malignant hyperthermia is a rare, life-threatening condition triggered by anesthesia in susceptible individuals. Early identification and available treatments can prevent fatalities from this hypermetabolic crisis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fatalities following topical application of local anesthetics to mucous membranes.

    Journal of the American Medical Association·2014
    Same author

    Saddle block anesthesia with nupercaine in obstetrics.

    American journal of obstetrics and gynecology·2010
    Same author

    Some hazards of anesthesia.

    The New Orleans medical and surgical journal·2010
    Same author

    Some practical aspects of the chemistry and pharmacology of local anesthetic drugs.

    Southern medical journal·2010
    Same author

    The efficiency of oenethyl (2, methyl amino heptane) as a vasopressor substance for spinal anesthesia.

    Anesthesiology·2010
    Same author

    Saddle block anesthesia with nupercaine for obstetrics.

    Southern medical journal·2010

    Area of Science:

    • Anesthesiology
    • Medical Genetics
    • Pharmacology

    Background:

    • Malignant hyperthermia (MH) is a severe hypermetabolic disorder with a genetic basis.
    • It is primarily triggered by volatile anesthetic agents and succinylcholine.
    • Fatalities have been documented in dental settings under general anesthesia.

    Observation:

    • MH can also be triggered by non-pharmacologic factors like stress, exercise, and muscle injury in susceptible individuals.
    • Clinical presentation involves rapid temperature increase, muscle rigidity, and metabolic derangement.
    • Identifying susceptible individuals and managing MH can be challenging due to its varied triggers and empiric treatment.

    Findings:

    • Established criteria exist for identifying individuals susceptible to malignant hyperthermia.
    • Effective prophylactic and therapeutic agents for MH are available.
    • This paper reviews MH features, diagnostic criteria, and management protocols.

    Implications:

    • Improved identification of susceptible patients can prevent MH episodes.
    • Availability of prophylactic and therapeutic agents enhances patient safety during anesthesia.
    • Understanding non-anesthetic triggers is crucial for managing MH in conscious patients.

    Related Experiment Videos